Rhythm Pharmaceuticals (RYTM) Treasury Shares (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Treasury Shares of $115000.0 for Q1 2026, down 23.33% year-over-year from $150000.0 in Q1 2025, and down 13.21% quarter-over-quarter from $132500.0 in Q4 2025.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) Treasury Shares (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Treasury Shares for 8 consecutive years, with $115000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares fell 23.33% year-over-year to $115000.0; the TTM figure through Mar 2026 stood at $115000.0 (down 23.33% YoY), while the FY2025 annual figure was $132500.0, down 92.75% from the prior year.
- Treasury Shares slipped to $115000.0 in Q1 2026 per RYTM's latest filing, from $132500.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $804797.0 in Q4 2022 and bottomed at $115000.0 in Q1 2026.
- Historically, Treasury Shares has averaged $216921.9 across 4 years, with a median of $150000.0 in 2024.
- Annual changes were most pronounced in 2022 — Treasury Shares jumped 84.76% — and 2026, when it dropped 23.33%.
- Rhythm Pharmaceuticals' Treasury Shares stood at $804797.0 in 2022, then slumped by 81.36% to $150000.0 in 2024, then fell by 11.67% to $132500.0 in 2025, then dropped by 13.21% to $115000.0 in 2026.
- Business Quant data shows RYTM's Treasury Shares at $115000.0 in Q1 2026, $132500.0 in Q4 2025, and $150000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Rhythm Pharmaceuticals | 7.05 Bn | 6.72 Bn | 62.32 Mn | 68.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68.82 Mn |
| Jun 30, 2026 | 68.82 Mn |
| Mar 31, 2026 | 115,000.00 |
| Mar 31, 2026 | 115,000.00 |
| Dec 31, 2025 | 132,500.00 |
| Dec 31, 2025 | 132,500.00 |
| Sep 30, 2025 | 150,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Sep 30, 2017 | 80.95 Mn |
| Sep 30, 2017 | 80.95 Mn |